REGENXBIO Inc.
RGNX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001590877
In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 1 sale; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in REGENXBIO Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- +17 vs. Q4 2023
- Shares held
- 42.6M
- +4.46M (+11.7%) vs. Q4 2023
- Total value
- $896.6M
- +$212.3M (+31.0%) vs. Q4 2023
- New holders
- 40
- 60 more added
- Sold out
- 23
- 53 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 165 | $504.6M |
| Q1 2026 | 178 | $355.1M |
| Q4 2025 | 174 | $593.1M |
| Q3 2025 | 166 | $399.2M |
| Q2 2025 | 159 | $344.9M |
| Q1 2025 | 164 | $298.0M |
| Q4 2024 | 177 | $325.2M |
| Q3 2024 | 186 | $458.1M |
| Q2 2024 | 181 | $511.9M |
| Q1 2024 | 188 | $896.6M |
| Q4 2023 | 171 | $684.3M |
| Q3 2023 | 160 | $610.3M |
| Q2 2023 | 167 | $742.1M |
| Q1 2023 | 175 | $700.0M |
| Q4 2022 | 182 | $808.9M |
| Q3 2022 | 183 | $926.6M |
| Q2 2022 | 166 | $895.7M |
| Q1 2022 | 187 | $1.16B |
| Q4 2021 | 172 | $1.16B |
| Q3 2021 | 183 | $1.40B |
| Q2 2021 | 172 | $1.30B |
| Q1 2021 | 184 | $1.12B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding REGENXBIO Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −15,828−100.0% | Sold out |
| Prentiss Smith & Co Inc | 0 | $0 | 0.00% | −10,107−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −1,682−100.0% | Sold out |
| Planned Solutions, Inc. | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −552−100.0% | Sold out |
| DAGCO, Inc. | 0 | $0 | 0.00% | −191−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |